Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino
Autor(a) principal: | |
---|---|
Data de Publicação: | 2005 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S1413-78522005000500005 http://repositorio.unifesp.br/handle/11600/2384 |
Resumo: | Osteoarthrosis is a chronic joint disease that, once patent, leads to a progressive functional disability. As proteochondroitin sulfates are the major contents of the cartilage, it is expected that the ingestion of glucosamine and chondroitin might improve the biological status of that tissue. As we could not find any studies on the pharmacokinetic profile of this association by oral administration route in human beings, the objective of this study was to evaluate it by using the association of glucosamine sulfate (GS) and chondroitin sulfate (CS) given to two groups of twelve healthy male volunteers (group I: one capsule containing 500 mg of GS and 400 mg of CS; group II: four capsules with the same content). Blood samples were collected at pre-determined time intervals up to 48 hours post-dosing. GS and CS were measured in plasma by the DMMB (1,9,dimethyl-dimethilene blue) method. Maximum concentration was achieved within 2 hours (average ± SE; 0.893±0.093 µg/ml, group I; and 2.222±0.313 µg/ml, group II). Areas under curve up to 48 hours were 10.803±0.965 µg-hr/ml and 38.776±2.981 µg-hr/ml for groups I and II, respectively. Both groups showed a second peak after 18 hours, indicating an enterohepatic flow. Our results indicate that this association is absorbed through the oral route by a saturable mechanism, which can enable its use in clinical treatments. |
id |
UFSP_c1d2729622641aef300b8202c25f276b |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/2384 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculinoPharmacokinetic profile of glucosamine and chondroitin sulfate association in healthy male individualsOsteoarthrosisChondroitin SulfateGlucosamineProteoglicansOsteoartroseSulfato de condroitinaGlucosaminaProteoglicanosOsteoarthrosis is a chronic joint disease that, once patent, leads to a progressive functional disability. As proteochondroitin sulfates are the major contents of the cartilage, it is expected that the ingestion of glucosamine and chondroitin might improve the biological status of that tissue. As we could not find any studies on the pharmacokinetic profile of this association by oral administration route in human beings, the objective of this study was to evaluate it by using the association of glucosamine sulfate (GS) and chondroitin sulfate (CS) given to two groups of twelve healthy male volunteers (group I: one capsule containing 500 mg of GS and 400 mg of CS; group II: four capsules with the same content). Blood samples were collected at pre-determined time intervals up to 48 hours post-dosing. GS and CS were measured in plasma by the DMMB (1,9,dimethyl-dimethilene blue) method. Maximum concentration was achieved within 2 hours (average ± SE; 0.893±0.093 µg/ml, group I; and 2.222±0.313 µg/ml, group II). Areas under curve up to 48 hours were 10.803±0.965 µg-hr/ml and 38.776±2.981 µg-hr/ml for groups I and II, respectively. Both groups showed a second peak after 18 hours, indicating an enterohepatic flow. Our results indicate that this association is absorbed through the oral route by a saturable mechanism, which can enable its use in clinical treatments.A osteoartrose é uma doença crônica das articulações que, uma vez instalada, leva seus portadores a uma incapacidade funcional progressiva. Como os proteocondroitins sulfato são os maiores constituintes das cartilagens, espera-se que com a ingestão de glucosamina e condroitina haja uma melhora das condições biológicas desse tecido. Uma vez que não temos conhecimento de estudo da farmacocinética da administração oral dessa associação em seres humanos, o objetivo deste trabalho foi avaliá-la utilizando a associação entre o sulfato de glucosamina (SG) e o sulfato de condroitina (SC) administrada a dois grupos de doze voluntários sadios do sexo masculino (grupo I uma cápsula de (500 mg SG; 400 mg SC) e grupo II quatro cápsulas). Amostras de sangue foram retiradas a intervalos de tempo pré-definidos até 48 horas pós-dose. O SG e o SC foram dosados no plasma pelo método de DMMB (azul de 1,9,dimetildimetileno). A concentração máxima foi atingida em 2 horas (média ±SE; 0,893±0,093 µg/mL, grupo I e 2,222±0,313 µg/mL, grupo II). As áreas sob a curva até 48 horas foram de 10,803±0,965 µg-hr/mL e 38,776±2,981 µg-hr/mL, respectivamente para os grupos I e II. Os dois grupos apresentaram um segundo pico após 18 horas, indicando circulação êntero-hepática. Os nossos resultados indicam que essa associação é absorvida por via oral por mecanismo saturável, o que pode facilitar o seu uso em tratamentos clínicos.Fundação Oswaldo Ramos Hospital do Rim e HipertensãoUNIFESP-EPMUNIFESP, EPMSciELOSociedade Brasileira de Ortopedia e TraumatologiaFundação Oswaldo Ramos Hospital do Rim e HipertensãoUniversidade Federal de São Paulo (UNIFESP)Toffoletto, OdalyTavares, Agostinho [UNIFESP]Casarini, Dulce Elena [UNIFESP]Redublo, Beata Marie [UNIFESP]Ribeiro, Artur Beltrame [UNIFESP]2015-06-14T13:31:25Z2015-06-14T13:31:25Z2005-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion235-237application/pdfhttp://dx.doi.org/10.1590/S1413-78522005000500005Acta Ortopédica Brasileira. Sociedade Brasileira de Ortopedia e Traumatologia, v. 13, n. 5, p. 235-237, 2005.10.1590/S1413-78522005000500005S1413-78522005000500005.pdf1413-7852S1413-78522005000500005http://repositorio.unifesp.br/handle/11600/2384porActa Ortopédica Brasileirainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-28T08:22:01Zoai:repositorio.unifesp.br/:11600/2384Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-28T08:22:01Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino Pharmacokinetic profile of glucosamine and chondroitin sulfate association in healthy male individuals |
title |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino |
spellingShingle |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino Toffoletto, Odaly Osteoarthrosis Chondroitin Sulfate Glucosamine Proteoglicans Osteoartrose Sulfato de condroitina Glucosamina Proteoglicanos |
title_short |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino |
title_full |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino |
title_fullStr |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino |
title_full_unstemmed |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino |
title_sort |
Farmacocinética da associação de glucosamina e sulfato de condroitina em humanos sadios do sexo masculino |
author |
Toffoletto, Odaly |
author_facet |
Toffoletto, Odaly Tavares, Agostinho [UNIFESP] Casarini, Dulce Elena [UNIFESP] Redublo, Beata Marie [UNIFESP] Ribeiro, Artur Beltrame [UNIFESP] |
author_role |
author |
author2 |
Tavares, Agostinho [UNIFESP] Casarini, Dulce Elena [UNIFESP] Redublo, Beata Marie [UNIFESP] Ribeiro, Artur Beltrame [UNIFESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Fundação Oswaldo Ramos Hospital do Rim e Hipertensão Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Toffoletto, Odaly Tavares, Agostinho [UNIFESP] Casarini, Dulce Elena [UNIFESP] Redublo, Beata Marie [UNIFESP] Ribeiro, Artur Beltrame [UNIFESP] |
dc.subject.por.fl_str_mv |
Osteoarthrosis Chondroitin Sulfate Glucosamine Proteoglicans Osteoartrose Sulfato de condroitina Glucosamina Proteoglicanos |
topic |
Osteoarthrosis Chondroitin Sulfate Glucosamine Proteoglicans Osteoartrose Sulfato de condroitina Glucosamina Proteoglicanos |
description |
Osteoarthrosis is a chronic joint disease that, once patent, leads to a progressive functional disability. As proteochondroitin sulfates are the major contents of the cartilage, it is expected that the ingestion of glucosamine and chondroitin might improve the biological status of that tissue. As we could not find any studies on the pharmacokinetic profile of this association by oral administration route in human beings, the objective of this study was to evaluate it by using the association of glucosamine sulfate (GS) and chondroitin sulfate (CS) given to two groups of twelve healthy male volunteers (group I: one capsule containing 500 mg of GS and 400 mg of CS; group II: four capsules with the same content). Blood samples were collected at pre-determined time intervals up to 48 hours post-dosing. GS and CS were measured in plasma by the DMMB (1,9,dimethyl-dimethilene blue) method. Maximum concentration was achieved within 2 hours (average ± SE; 0.893±0.093 µg/ml, group I; and 2.222±0.313 µg/ml, group II). Areas under curve up to 48 hours were 10.803±0.965 µg-hr/ml and 38.776±2.981 µg-hr/ml for groups I and II, respectively. Both groups showed a second peak after 18 hours, indicating an enterohepatic flow. Our results indicate that this association is absorbed through the oral route by a saturable mechanism, which can enable its use in clinical treatments. |
publishDate |
2005 |
dc.date.none.fl_str_mv |
2005-01-01 2015-06-14T13:31:25Z 2015-06-14T13:31:25Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S1413-78522005000500005 Acta Ortopédica Brasileira. Sociedade Brasileira de Ortopedia e Traumatologia, v. 13, n. 5, p. 235-237, 2005. 10.1590/S1413-78522005000500005 S1413-78522005000500005.pdf 1413-7852 S1413-78522005000500005 http://repositorio.unifesp.br/handle/11600/2384 |
url |
http://dx.doi.org/10.1590/S1413-78522005000500005 http://repositorio.unifesp.br/handle/11600/2384 |
identifier_str_mv |
Acta Ortopédica Brasileira. Sociedade Brasileira de Ortopedia e Traumatologia, v. 13, n. 5, p. 235-237, 2005. 10.1590/S1413-78522005000500005 S1413-78522005000500005.pdf 1413-7852 S1413-78522005000500005 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Acta Ortopédica Brasileira |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
235-237 application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Ortopedia e Traumatologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Ortopedia e Traumatologia |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268397114884096 |